Abstract:Multiple myeloma (MM) is an incurable B-cell malignancy. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission. Arsenic trioxide (As2O3) is an effective treatment for acute promyelocytic leukemia. Current clinical studies are investigating arsenic as a therapeutic agent for malignancies. The mechanism of cytotoxicity inducted by As2O3 has not been known thoroughly. Constitutively activated NF-κB is a characteristic of different tumor entities including MM clones and malignant plasma cells from MM patients. It plays an important role in maintaining tumor cell proliferation and protecting cell from apoptosis. The study was to explore the possible mechanism of As2O3 effects on MM lines. Materials and methods: The human MM cell lines of KM3 and RPMI8226 were provided by Hematology Institution of Zhejiang University. The concentration of As2O3 in cell culture system was from 0.5μmol/L to 20μmol/L, 24 hours was selected as the termination point of cell culture. Cell culture without As2O3 and first-antibody-dismissed test were enrolled as controls. Both of the MM lines were treated with As2O3 in various concentrations. The restrained proliferation was observed by drawing growth curve. MTT bioassay was used to examine the effect of As2O3 on cell growth and the concentration of 50% growth inhibition( IC50) calculated respectively. Apoptosis and changes of IκB-α protein was observed by flow cytometry(FCM). Changes and subcellular localization of IκB-α protein were observed by fluorescence microscopy. Western blot was also used to analyze the expression of NF-κB in nuclear. Results: As2O3 inhibited the proliferation of both MM lines, and IC50 of KM3 and RPMI8226 was 9.61μmol/L and 8.01μmol/L respectively. After exposure to As2O3, both of the lines were induced to apoptosis. With As2O3 concentration varied from 0.5μmol/L to 20μmol/L the apoptosis rate of KM3 and RPMI8226 was concentration-dependent measured by FCM. After 24 hours treated with 20μmol/L As2O3, the apoptosis rate of KM3 cells was 41.18% while that of RPMI8226 was 65.25%. It seemed that RPMI8226 cell was more sensitive to As2O3. FCM analysis showed a significant increase in the percentage of G2/M phase cells, from 13.74% to 41.72%, and a decrease percentage of S phase cells from 35.11% to 23.96%. The level of IκB-α in cytoplasm was down-regulated after As2O3 stimulation in both cell lines. The down-regulation of IκB-α from 79.68% to 51.57% was confirmed by FCM in KM3 treated with 10μmol/L As2O3 (p<0.01), the effect was concentration-dependent. While the IκB-α in RPMI8226 changed from 79.72% to 34.08% (p<0.01). Immunofluorescence assay showed that IκB-α localized in cytoplasm mostly. The level of IκB-α protein was down-regulated after As2O3 stimulation. The results showed that KM3 and RPMI8226 lines expressed constitutively activity NF-κB and As2O3 down-regulated the constitutive expression of NF-κB in both cell lines but with different kinetics. Conclusions: As2O3 could not only inhibit the proliferation but also induce apoptosis of KM3 and RPMI8226 cells. The mechanisms of its effect on MM cells may include decreasing the constitutive activity of NF-κB, subsequently down-regulating the expression of various gene products controlled by NF-κB, thus inducing apoptosis in MM cells. As2O3 could inhibit the proliferation of MM cells by changing MM cell cycle and inducing G2/M phase arrest.

Arsenic Trioxide Re-Sensitizes Er Alpha-Negative Breast Cancer Cells To Endocrine Therapy By Restoring Er Alpha Expression In Vitro And In Vivo

Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.

Arsenic Induces Functional Re-Expression of Estrogen Receptor Α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer

Mechanism Of Arsenic Trioxide-Induced Apoptosis On Multiple Myeloma Cells.

Arsenic Trioxide Induces Apoptosis in MDS Cell Line MUTZ-1 Cells Via Caspase-Dependent Pathways and Down Regulation of Htert

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.

[Expression of ER Alpha in Chemically Induced MDA-MB-435 Cells and Its Responsiveness to Endocrine].

ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor

[Primary Research on Arsenic Trioxide Inhibiting Human Breast Cancer Cells Growth and Its Mechanisms].

The Comparison of the Expression Effect of ER-α Induced by Arsenic Trioxide and Hydrazine

Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIMEL to attenuate apoptosis in BEAS-2B cells

Induction of the Mesenchymal to Epithelial Transition by Demethylation- Activated Microrna-200C is Involved in the Anti-Migration/invasion Effects of Arsenic Trioxide on Human Breast Cancer Cells.

The study of arsenic trioxide on the effect at medroxyprogesterone acetate resistant endometrial carcinoma cells

Effect of arsenic trioxide on growth of a heterologous graft model for human breast cancer in nude mice

Arsenic Trioxide Reduces the Invasive and Metastatic Properties of Nasopharyngeal Carcinoma Cells in Vitro.

[Impact of Arsenic Trioxide on Proliferation and Metastasis of Drug-Resistant Human Ovarian Carcinoma Cell Line].

[Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms]

Arsenic Trioxide Inhibits DNA Methyltransferase and Restores TMS1 Gene Expression in K562 Cells.

Arsenic Trioxide Induces Apoptosis in Cisplatin-Sensitive and -Resistant Ovarian Cancer Cell Lines

Arsenic trioxide inhibition of tumor growth of subcutaneously implanted human breast cancer cells and its mechanism

The combination of arsenic and cryptotanshinone induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in breast cancer cells.